Enavate Sciences’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.3M Hold
4,768,583
25.12% 1
2025
Q1
$32.1M Buy
4,768,583
+1,290,322
+37% +$8.68M 24.18% 1
2024
Q4
$36.9M Buy
+3,478,261
New +$36.9M 26.53% 2